PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon Research Solutions, Inc. Announces New Agreement with Biogen Idec - Chairman and CEO, Jim Walker of Octagon Research Solutions, Inc., announced today that Biogen Idec, (NASDAQ: BIIB), will begin using StartingPoint® and eCTD JumpStart™ as the foundation of their electronic submission strategy
Octagon Research Solutions, Inc. Announces New Agreement with Biogen Idec

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2007/02/26 - Chairman and CEO, Jim Walker of Octagon Research Solutions, Inc., announced today that Biogen Idec, (NASDAQ: BIIB), will begin using StartingPoint® and eCTD JumpStart™ as the foundation of their electronic submission strategy.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Company chooses StartingPoint® and eCTD JumpStart™ to implement global authoring standards.

Chairman and CEO, Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, announced today that Biogen Idec, (NASDAQ: BIIB), a premier biotechnology organization that has pioneered important medical advances worldwide, will begin using StartingPoint® and eCTD JumpStart™ as the foundation of their electronic submission strategy.

“We are very excited that Biogen Idec has chosen both of these solutions which will provide the company with a strong electronic submission foundation and further develop their eCTD processes” stated John Lawrie, vice president, Process Solutions at Octagon. “Our StartingPoint and eCTD JumpStart solutions encapsulate deep domain knowledge and the practical experience of some of the industry’s leading experts in electronic submissions and in combination with our training and consulting services, provide a basis for efficient implementation of eCTD standards and processes.

Octagon’s Chairman and CEO Jim Walker added, “The market validation we receive when a global biotechnology company such as Biogen Idec chooses the unique combination of technology and expertise inherent in our StartingPoint and eCTD JumpStart solutions, confirms that our targeted eCTD solutions are resonating throughout industry.”

Octagon understands the challenges of implementing global authoring standards across an organization and how the implementation of these standards can become a catalyst for change. StartingPoint® 2.2 Global eCTD Template Suite, originally launched in 2003, includes a master template, which defines formatting, and automation functionality, over 175 authoring templates across all five CTD modules, validation test scripts and a comprehensive user guide, EU Content templates for Module 1 and a PLR (Physician’s Labeling Rule) button, which enables users to easily generate the compliant two-column format required by the FDA. StartingPoint’s automated toolbar provides functionality for custom styles, pre-formatted tables, page orientation, frequently used symbol characters, and instructional text regarding content and format.

eCTD JumpStart™ includes a Style Guide, Document Naming Conventions, a Folder Structure for storing and managing Regulatory Submission Documents, and Bookmarking and Hyperlinking Standards. In addition, it includes consulting services which address how document processes can pull together all of these standards to facilitate the efficient creation, management, and retrieval of submission-ready documents. These components have been honed through Octagon’s collective breadth of knowledge and experience from having prepared hundreds of electronic submissions since the company’s inception.

About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional electronic submission expertise, a holistic process approach, deep domain knowledge, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Amersham, UK.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. Announces New Agreement with Biogen Idec

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Graham 
610 535 6500 ext 5655 jgraham[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)